Fact CheckerSign in

NCT07627022Not yet recruiting

Impact of a Reminder App on Physical Activity During Radiation Therapy for Lung Cancer

Source: ClinicalTrials.gov · Last updated 4 Jun 2026

Brief summary (registry, in English)

The primary objective of this prospective randomized trial is to explore whether the use of a smart phone-based reminder application is associated with a change in physical activity during radiation therapy in patients with lung cancer. The primary endpoint focuses on the within-patient change in physical activity between Week 1 and Week 5, with comparison between treatment groups to assess potential differences attributable to the intervention. Secondary objectives include the exploratory assessment of patient satisfaction with the reminder app, its impact on the use and perception of digital health technology. A total of 28 evaluable patients in the Full Analysis Set (approximately 14 per treatment arm) are required to detect a clinically relevant difference corresponding to a probability of superiority of approximately 0.65 with 80% power at a two-sided significance level of 0.05. Assuming that approximately 10% of patients will not be evaluable for the primary endpoint, a total of 32 patients will be randomized.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
32 (estimated)
First submitted
31 May 2026
Start date
1 Jul 2026
Primary completion date
15 Feb 2027
Lead sponsor
University Hospital Schleswig-Holstein
Diseases
Lung cancer
NCT number
NCT07627022

What you commit to

  • Study type: Interventional
  • Planned participants: 32
  • From 1 Jul 2026 to the primary completion date, 15 Feb 2027
  • 7 sites in 4 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • 1\. Expected non-compliance

Who the study is looking for

  • Histologically proven lung cancer
  • Treatment with ≥50 Gy of conventionally fractionated radiation therapy
  • Possession of and ability to use a smart phone plus a step counter
  • Age ≥18 years
  • Written informed consent
  • Capacity of the patient to consent

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (7)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
MVZ RON Niedersachsen Strahlentherapie GmbH
Coordinator of this site? Confirm its status
HanoverGermanyUnknown status
Department of Radiation Oncology, Christian-Albrechts University
Coordinator of this site? Confirm its status
KielGermanyUnknown status
Department of Radiation Oncology, University of Luebeck
Coordinator of this site? Confirm its status
LübeckGermanyUnknown status
Department of Pulmonology, University of Luebeck
Coordinator of this site? Confirm its status
LübeckGermanyUnknown status
Department of Oncology Vejle Hospital, University Hospital of Southern Denmark
Coordinator of this site? Confirm its status
VejleDenmarkUnknown status
Radiation Oncology Department, Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic
Coordinator of this site? Confirm its status
TbilisiGeorgiaUnknown status
Department of Radiotherapy, Institute of Oncology Ljubljana and Faculty of Medicine, University of Ljubljana
Coordinator of this site? Confirm its status
LjubljanaSloveniaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.